1-5 of 5
Antonello Di Paolo
Close
Sort by
Journal Articles

Pharmacogenomics Drives Lenalidomide Efficacy and MRD Kinetics in Mantle Cell Lymphoma after Autologous Transplantation: Results from the MCL0208 Multicenter, Phase III, Randomized Clinical Trial from the Fondazione Italiana Linfomi (FIL)

Simone Ferrero, MD, Daniele Grimaldi, MD, Elena Arrigoni, Gian Maria Zaccaria, PhD, Beatrice Alessandria, Elisa Genuardi, Gabriele De Luca, Marco Ghislieri, Alice Di Rocco, Alessandro Re, MD, Vittorio Stefoni, MD PhD, Federica Cavallo, Carola Boccomini, MD, Monica Balzarotti, Vittorio Ruggero Zilioli, MD, Gomes da Silva Maria, MD PhD, Luca Arcaini, Anna Lia Molinari, MD, Filippo Ballerini, MD, Andres JM Ferreri, MD, Benedetta Puccini, Giuseppe A. Palumbo, MD PhD, Sara Galimberti, MD PhD, Sergio Cortelazzo, MD, Antonello Di Paolo, Marco Ladetto, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-134875
Published: 2020
Journal Articles

Delphi, a Data Warehouse to Discover Associations between Variables in Clinical Trials: Application to the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

Gian Maria Zaccaria, MSc, Simone Ferrero, Andrea Evangelista, Samanta Rosati, Cristina Castagneri, Marco Ghislieri, Barbero Daniela, Elisa Genuardi, Mariella Lo Schirico, Alberto Zamò, Umberto Vitolo, Riccardo Bomben, Valter Gattei, MD, Sara Galimberti, PhD MD, Antonello Di Paolo, Davide Rossi, MD PhD, Gianluca Gaidano, MD PhD, Alice Di Rocco, Sergio Cortelazzo, Mario Boccadoro, Gabriella Balestra, Marco Ladetto
Journal: Blood
Blood (2017) 130 (Supplement 1): 3451.
https://doi.org/10.1182/blood.V130.Suppl_1.3451.3451
Published: 2017
Journal Articles

The hOCT1 and ABCB1 Polymorphisms Don't Condition the Efficacy and Toxicity of Nilotinib As First-Line Treatment: An Italian Multicentric Experience

Sara Galimberti, MD PhD, Cristina Bucelli, MD, Elena Arrigoni, PhD, Claudia Baratè, Susanna Grassi, Federica Ricci, MD, Francesca Guerrini, PhD, Elena Ciabatti, PhD, Carmen Fava, MD, Antonio D'Avolio, Giulia Fontanelli, MD, Giovanna Rege Cambrin, MD, Alessandro Isidori, MD PhD, Federica Loscocco, PhD, Giovanni Caocci, MD, Marianna Greco, PhD, Monica Bocchia, MD, Lara Aprile, MD, Antonella Gozzini, MD, Barbara Scappini, MD, Daniele Cattaneo, MD, Giorgio La Nasa, MD, Alberto Bosi, MD, Mario Petrini, MD PhD, Pietro Leoni, MD, Romano Danesi, MD PhD, Giuseppe Saglio, MD PhD, Giuseppe Visani, MD, Agostino Cortellezzi, MD, Anna Rita Scortechini, MD, Alessandra Iurlo, MD, Antonello Di Paolo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3951.
https://doi.org/10.1182/blood.V128.22.3951.3951
Published: 2016
Journal Articles

Combined Famd and ANOVA Investigation Leads to Significant Association Between the hOCT1/ABCB1 Diplotype and Both Efficacy and Tolerability in Patients Affected By Chronic Myeloid Leukemia

Sara Galimberti, MD, Laura Galeotti, Francesco Ceccherini, Dario Domingo, Marco Laurino, Marialuisa Polillo, Antonello Di Paolo, Claudia Baratè, MD, Carmen Fava, MD, Antonio D'Avolio, Giulia Fontanelli, Romano Danesi, Fulvio Cornolti, Francesca Guerrini, Elena Ciabatti, Giuseppe Saglio, MDPhD, Mario Petrini
Journal: Blood
Blood (2015) 126 (23): 4838.
https://doi.org/10.1182/blood.V126.23.4838.4838
Published: 2015
Journal Articles

Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib

Sara Galimberti, MD PhD, Laura Galeotti, PhD, Francesco Ceccherini, PhD, Marialuisa Polillo, Dr, Claudia Baratè, MD, Giulia Fontanelli, MD, Francesca Guerrini, PhD, Roberta Arici, ScD, Sara Barsotti, MD, Federica Ricci, Lara Aprile, MD, Fulvio Cornolti, Prof., Mario Petrini, MD, Monica Bocchia, MD PhD Prof., Antonello Di Paolo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3608.
https://doi.org/10.1182/blood.V124.21.3608.3608
Published: 2014